Literature DB >> 16848926

Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.

G Cilla1, E Pérez-Trallero, J Artieda, E Serrano-Bengoechea, M Montes, D Vicente.   

Abstract

The aim of this study was to determine changes in the epidemiology of hepatitis A virus (HAV) infection in the Basque Country, Spain, and to evaluate their implications for vaccination strategies. A total of 1356 persons were enrolled in a study of the prevalence of anti-HAV in 2004 and compared with two previous studies (1986-1987 and 1992). The selection method and the characteristics of the population were similar in the three studies. A marked decline in the seroprevalence in all age groups (P<0.001) and in the incidence of cases/100,000 inhabitants (from 38.0 in 1986-1988 to 2.9 in 2002-2004) were observed. The mean age of patients with hepatitis A increased from 17.7 years in 1986-1992 to 21.2 years in 1993-1998 and 25.3 years in 1999-2004 (P<0.001). Between 1997 and 2004, 20% of patients were hospitalized. The changes observed have occurred rapidly causing a change in the epidemiological pattern from middle-high endemicity (1986) to low endemicity (2004).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848926      PMCID: PMC2870586          DOI: 10.1017/S0950268806006959

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Hepatitis A vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-02-04

2.  Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)?

Authors:  P L Lopalco; L Salleras; S Barbuti; C Germinario; M Bruguera; M Buti; A Domínguez
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

3.  A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.

Authors:  R Dal-Ré; P García-Corbeira; J García-de-Lomas
Journal:  J Med Virol       Date:  2000-04       Impact factor: 2.327

4.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-10-01

5.  Guidelines for the control of hepatitis A virus infection.

Authors:  N S Crowcroft; B Walsh; K L Davison; U Gungabissoon
Journal:  Commun Dis Public Health       Date:  2001-09

6.  Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak.

Authors:  C J Staes; T L Schlenker; I Risk; K G Cannon; H Harris; A T Pavia; C N Shapiro; B P Bell
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

7.  Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

Authors:  W Thierfelder; W Hellenbrand; H Meisel; E Schreier; R Dortschy
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Vaccination strategies against hepatitis A in southern Europe.

Authors:  Elisabetta Franco; Giuseppe Vitiello
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

Review 9.  HAV infection in chronic liver disease: a rationale for vaccination.

Authors:  Piero L Almasio; Pietro Amoroso
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

Review 10.  Hepatitis A booster vaccination: is there a need?

Authors:  P Van Damme; J Banatvala; O Fay; S Iwarson; B McMahon; K Van Herck; D Shouval; P Bonanni; B Connor; G Cooksley; G Leroux-Roels; F Von Sonnenburg
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

View more
  3 in total

1.  Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Authors:  Eduardo Lazcano-Ponce; Carlos Conde-Gonzalez; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

2.  Seroepidemiology of hepatitis a in the croatian population.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Suncanica Ljubin-Sternak; Branko Kolaric
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

3.  Outbreak of hepatitis A in a nursery school.

Authors:  Antonia Galmes-Truyols; Jaume Gimenez-Duran; Antonio Nicolau-Riutort; Catalina Bosch-Isabel; Juana Maria Vanrell-Berga; Margarita Portell-Arbona
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.